Dr. Gina Wallar currently serves as the President, Pharma Services Division at NeoGenomics Laboratories, a global leader in clinical laboratory, pharma services and information services that specializes in cancer genetics diagnostic testing. Prior to that, from 2016 – 2018, she served as NeoGenomics’ Senior Vice President, Clinical Division. Dr. Wallar joined the company in 2014 as Director, Scientific Affairs and Project Management, having previously served as the Director for LabCorp Clinical Trials for over 12 years. Dr. Wallar brings significant experience in the Life Sciences space with progressively responsible roles throughout her career. Dr. Wallar received her MPH in Epidemiology and Biostatistics from Boston University and received her PhD at UCLA in Cancer Epidemiology.